jan 1, 2001 - New targeted therapy transforms treatment for rare leukemia

Description:

FDA approves imatinib after just three monthes of review based on data showing that the drug halted the growth of CML.

Added to timeline:

16 Nov 2018

0

0

254

Cancer Dates

Date: